What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His main research concerns Surgery, Chemotherapy, Radiation therapy, Internal medicine and Cancer.
His studies link Glioma with Surgery.
His work in Chemotherapy tackles topics such as Atypical teratoid rhabdoid tumor which are related to areas like Teratoid tumor.
The various areas that Jonathan L. Finlay examines in his Radiation therapy study include Clinical trial and Ependymoma.
His Internal medicine research integrates issues from Gastroenterology and Oncology.
His Cancer research incorporates elements of Young adult, El Niño, Pediatrics and Prospective cohort study, Pathology.
His most cited work include:
- Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study (568 citations)
- Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas (469 citations)
- Central Nervous System Atypical Teratoid/Rhabdoid Tumor: Results of Therapy in Children Enrolled in a Registry (327 citations)
What are the main themes of his work throughout his whole career to date?
Jonathan L. Finlay mainly investigates Internal medicine, Chemotherapy, Oncology, Surgery and Pathology.
The Internal medicine study combines topics in areas such as Head start and Glioma.
As part of the same scientific family, Jonathan L. Finlay usually focuses on Chemotherapy, concentrating on Radiation therapy and intersecting with Brain tumor and Ependymoma.
Jonathan L. Finlay works mostly in the field of Oncology, limiting it down to topics relating to Medulloblastoma and, in certain cases, Methotrexate.
His study brings together the fields of Gastroenterology and Surgery.
Jonathan L. Finlay has included themes like Germline mutation, Germinoma, Central nervous system, Choroid plexus and Germ cell tumors in his Pathology study.
He most often published in these fields:
- Internal medicine (43.53%)
- Chemotherapy (36.47%)
- Oncology (36.71%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (43.53%)
- Oncology (36.71%)
- Cancer research (13.65%)
In recent papers he was focusing on the following fields of study:
Jonathan L. Finlay mostly deals with Internal medicine, Oncology, Cancer research, Medulloblastoma and Chemotherapy.
Jonathan L. Finlay combines subjects such as Exome sequencing, BRAF V600E and Mutation with his study of Internal medicine.
He interconnects Glioma, Radiation therapy, Head start and Objective in the investigation of issues within Oncology.
His Radiation therapy research includes themes of Primary tumor and Metastasis.
His work on Desmoplastic/Nodular Medulloblastoma is typically connected to Profiling as part of general Medulloblastoma study, connecting several disciplines of science.
His research combines Everolimus and Chemotherapy.
Between 2017 and 2021, his most popular works were:
- Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas (47 citations)
- Pediatric choroid plexus carcinoma: Biologically and clinically in need of new perspectives. (13 citations)
- Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015. (12 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Internal medicine, Oncology, Chemotherapy, Cancer research and Medulloblastoma are his primary areas of study.
As part of one scientific family, Jonathan L. Finlay deals mainly with the area of Internal medicine, narrowing it down to issues related to the Exome sequencing, and often MAPK/ERK pathway, Survival analysis, ROS1 and Receptor tyrosine kinase.
His work deals with themes such as Germinoma, Hematology, Mutation, Glioma and BRAF V600E, which intersect with Oncology.
His studies deal with areas such as CNS TUMORS, Central nervous system and Head start as well as Chemotherapy.
His Carboplatin research incorporates themes from ThioTEPA and Etoposide.
His Consolidation Chemotherapy study is associated with Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
